logo-loader
viewAroa Biosurgery Ltd

Aroa Biosurgery makes its debut on the ASX exchange under code ARX

 

Aroa Biosurgery (ASX: ARX) CEO Dr Brian Ward joined Steve Darling from Proactive to bring news the company will be trading on the ASX under the code ARX. Dr Ward discusses this milestone for the company that does soft tissue regeneration using their Endoform platform technology.

Dr Ward also told Proactive about some of the other milestones the company has achieved this year and what the rest of 2020 will look like.

Quick facts: Aroa Biosurgery Ltd

Price: 1.42 AUD

ASX:ARX
Market: ASX
Market Cap: $426.11 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Aroa Biosurgery Ltd named herein, including the promotion by the Company of Aroa Biosurgery Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read